Tufia C. Haddad

Also affiliated with WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 17 papers. Top paper: “Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α”.

Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3091

N/A

1.4DataRank · unranked

41 citations

Junmei Cairns, Vera J. Suman, Lois E. Shepherd, Peter A. Fasching, Tanya L. Hoskin +19 more

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2022.7949

N/A

1.4DataRank · unranked

52 citations

Vera J. Suman, Antonino B. D’Assoro, Jodi M. Carter, Karthik V. Giridhar, Brendan P. McMenomy +18 more

Modernizing the Data Infrastructure for Clinical Research to Meet Evolving Demands for Evidence

JAMA(2024)10.1001/jama.2024.0268

N/A

0.940DataRank · unranked

25 citations

Caroline Marra, Atul Janardhan Butte, Laura Esserman, Lee A. Fleisher, Cynthia I. Grossman +64 more

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer

Journal of Clinical Oncology(2020)10.1200/jco.19.02190

N/A

0.709DataRank · unranked

112 citations

Chunling Hu, Steven N. Hart, Nicholas Boddicker, Eric C. Polley, Jie Na +22 more

The Integration of Clinical Trials With the Practice of Medicine

JAMA(2024)10.1001/jama.2024.4088

N/A

0.646DataRank · unranked

73 citations

Alison J. Huang, Roger J. Lewis, Amy P. Abernethy, Robert M. Califf, Martin Landray +63 more

Five-Year Cumulative Incidence of Axillary Web Syndrome and Comparison in Upper Extremity Movement, Function, Pain, and Lymphedema in Survivors of Breast Cancer With and Without Axillary Web Syndrome

Archives of Physical Medicine and Rehabilitation(2022)10.1016/j.apmr.2022.03.007

N/A

0.627DataRank · unranked

15 citations

Amanda Day, David W. Hunter, Anne Blaes, Tufia C. Haddad, Ryan Shanley +1 more

MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Academic Radiology(2020)10.1016/j.acra.2020.10.020

N/A

0.624DataRank · unranked

63 citations

Daniel Gomez‐Cardona, Christopher Favazza, Tanya L. Hoskin, Tufia C. Haddad, Matthew P. Goetz +2 more

The Growing Role of Digital Health Tools in the Care of Patients with Cancer: Current Use, Future Opportunities, and Barriers to Effective Implementation

Current Oncology Reports(2024)10.1007/s11912-024-01534-5

N/A

0.606DataRank · unranked

15 citations

Jonas Paludo, Tufia C. Haddad, Joshua C. Pritchett, Robert Haemmerle

Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy

Annals of Oncology(2021)10.1016/j.annonc.2021.02.011

N/A

0.574DataRank · unranked

45 citations

Christina Yau, Lamorna Brown Swigart, Rebekah Gould, Gregor Krings, Gillian L. Hirst +27 more

Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy

Circulation Cardiovascular Quality and Outcomes(2020)10.1161/circoutcomes.119.005984

N/A

0.515DataRank · unranked

30 citations

Lindsey R. Sangaralingham, Holly Van Houten, Somaira Nowsheen, Nicole P. Sandhu, Javid J. Moslehi +9 more

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2256

N/A

0.457DataRank · unranked

20 citations

Christina Yau, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien +44 more

Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0341

N/A

0.303DataRank · unranked

4 citations

Vera J. Suman, Karthik V. Giridhar, Kostandinos Sideras, Donald W. Northfelt, Brenda Ernst +15 more

Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer

Frontiers in Oncology(2024)10.3389/fonc.2024.1384277

N/A

0.269DataRank · unranked

5 citations

Minzhi Zhang, Mohammad Jalalirad, Roberto Leon Ferre, Royal Shrestha, Tufia C. Haddad +12 more

Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010

JAMA Network Open(2023)10.1001/jamanetworkopen.2022.54669

N/A

0DataRank · unranked

99 citations

Mariana Garcia‐Arango, Harika Dasari, Maria Arciniegas Calle, Effie Adjei, Juan Rico Mesa +8 more

Clinical Management of Metastatic Hormone Receptor-Positive, HER2-negative Breast Cancer (MBC) After CDK 4/6 inhibitors: A Retrospective Single-Institution Study

Research Square(2022)10.21203/rs.3.rs-1601792/v1

N/A

0DataRank · unranked

0 citations

S. Liddell, Roberto A. Leon‐Ferre, Ciara C. O’Sullivan, Kathryn J. Ruddy, Tufia C. Haddad +6 more

Major Adverse Cardiovascular Events in Patients Treated With Anthracyclines for Breast Cancer or Lymphoma: 25-Year Follow-Up

Research Square(2025)10.21203/rs.3.rs-6778136/v1

N/A

0DataRank · unranked

0 citations

Andres E. Daryanani Acevedo, M Roa, Carolina Ricaurte, Carolyn Larsen, Joerg Herrmann +5 more

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance

Oncogene(2021)10.1038/s41388-021-01711-x

N/A

0DataRank · unranked

103 citations

Tufia C. Haddad, Jeffrey L. Salisbury, Derek C. Radisky, Minzhi Zhang, Mark A. Schroeder +16 more